TheDapa-M
Advanced Dual-Action Diabetes Management
Composition
Dapagliflozin 10mg & Metformin Hydrochloride (ER) 500mg Tablets
Description
TheDapa-M combines two effective diabetes medications:
- Dapagliflozin: An SGLT2 inhibitor that reduces blood glucose by increasing glucose excretion
- Metformin ER: Improves insulin sensitivity and reduces hepatic glucose production
The extended-release formulation provides sustained glucose control throughout the day.
Recommended Usage
Take as prescribed by your healthcare provider, typically once daily in the morning with breakfast. Regular monitoring of kidney function is recommended.
Product by Willkings Healthcare.
Key Benefits
- Dual mechanism of action for better glycemic control
- Weight management support
- Cardiovascular benefits
- Once-daily extended-release formulation